TKG’s Healthcare Insights podcast hosted by vice president Warren Smedley recently spoke with Alyssa Schatz, senior director, policy and advocacy at the National Comprehensive Cancer Network® (NCCN®) about the organization’s strategic priorities.
Author: tkgadmin
Rachel DiPietro Serves as Moderator for AMCP Nexus 2022
Rachel DiPietro, vice president, moderated a session, “The Accelerated Approval Pathway: Current Challenges and the Managed Care Impact,” for the Academy of Managed Care Pharmacy (AMCP) Nexus 2022 conference.
The Kinetix Group’s Warren Smedley Joins Thought Leaders in Telehealth Awareness Week Panel
NEW YORK — October 2022 — Warren Smedley, DSc (can), MSHA, MSHQS, vice president at The Kinetix Group (TKG), joined thought leaders in a panel hosted by the American Telemedicine Association (ATA).
Impact of Iron Deficiency Related to Reproductive Health and Quality of Life
The Women’s Health research Collaborative presents a CME-sponsored course for physicians, specialists and other relevant practitioners.
Summer Interns Featured in TKG Healthcare Insights Three-Part Podcast Series
The Kinetix Group (TKG) worked with four dynamic interns this past summer. They were staffed under various teams to develop skills in client services, brand marketing and key opinion leader engagement.
As part of the internship program, the interns researched U.S. health equity trends and shared key learnings with TKG’s Healthcare Insights podcast.
BHN Spotlight #1: Dementia Care Pathway with Ochsner Health System
Dr. R. John Sawyer and his team at Ochsner Health System (OHS) developed a comprehensive care pathway to help address barriers to dementia.
Do You Know Where Your Infusion Products Are Going?
When your company sells oncology infusion therapies to a PBM, you might assume a large portion will be used in the hospital setting.
Moving the Needle on Patient Satisfaction Without Adding to Physician Burnout
Patient satisfaction is more important than ever. But oncology care teams are already overwhelmed.
Oncology Practice Consolidation & Emerging Organizational Needs
Increases in oncology practice consolidation will require life science companies to re-evaluate their customer engagement strategies and provide newly integrated practices with tools to succeed.
Accelerating the Adoption and Diffusion of New Cancer Drugs
In today’s oncology landscape, a thoughtful and intentional approach is needed to minimize the length of time it takes to get new drugs into regular clinical use.